Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

被引:86
作者
Eikenboom, JCJ [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Haematol, Haemostasis & Thrombosis Res Ctr, NL-2300 RC Leiden, Netherlands
关键词
von Willebrand disease; von Willebrand factor; drug therapy; antibodies; factor VIII; congenital; genetics; mutation;
D O I
10.1053/beha.2001.0139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand disease type 3 is the most severe form of this condition. Patients present with a moderate-to-severe bleeding tendency. The plasma von Willebrand factor level in these patients is very low or undetectable. Although rare, von Willebrand disease type 3 is of major interest because of its severe clinical presentation, the need for replacement therapy and the risk of occurrence of alloantibodies after the infusion of plasma concentrates. The inheritance of type 3 disease is typically autosomal recessive. The parents are often consanguineous, although compound heterozygous inheritance does occur. The molecular basis of von Willebrand disease type 3 has recently been studied in detail, several molecular defects being identified. This chapter will focus on the clinical and molecular aspects of type 3 von Willebrand disease.
引用
收藏
页码:365 / 379
页数:15
相关论文
共 86 条
[1]  
Abuzenadah AM, 1999, THROMB HAEMOSTASIS, P283
[2]  
Aledort LM, 2000, THROMB HAEMOSTASIS, V83, P637
[3]  
Allen S, 2000, BLOOD, V96, P560
[4]   A STOP CODON IN A PATIENT WITH SEVERE TYPE-III VONWILLEBRAND DISEASE [J].
BAHNAK, BR ;
LAVERGNE, JM ;
ROTHSCHILD, C ;
MEYER, D .
BLOOD, 1991, 78 (04) :1148-1149
[5]  
BAHNAK BR, 1988, THROMB HAEMOSTASIS, V60, P178
[6]  
Baronciani L, 2000, THROMB HAEMOSTASIS, V84, P536
[7]   Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction [J].
Batlle, J ;
Loures, E ;
Vila, P ;
Hernandez, MC ;
Mendez, JA ;
Torea, J ;
Rendal, E ;
Couselo, MJ ;
Filgueira, A ;
Lopez, MF ;
Fernandez .
ANNALS OF HEMATOLOGY, 1997, 75 (03) :111-115
[8]  
BERGAMASCHINI L, 1995, J LAB CLIN MED, V125, P348
[9]   A RELATIVELY HIGH-FREQUENCY OF SEVERE (TYPE-III) VONWILLEBRANDS DISEASE IN ISRAEL [J].
BERLINER, SA ;
SELIGSOHN, U ;
ZIVELIN, A ;
ZWANG, E ;
SOFFERMAN, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1986, 62 (03) :535-543
[10]   CHARACTERIZATION OF POLYMORPHIC MARKERS IN THE VONWILLEBRAND-FACTOR GENE AND PSEUDOGENE [J].
BERNARDI, F ;
MARCHETTI, G ;
CASONATO, A ;
GEMMATI, D ;
PATRACCHINI, P ;
LEGNANI, C ;
DEROSA, V ;
GIROLAMI, A ;
CONCONI, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) :282-289